(10-366) Impact of Clozapine Risk Evaluation and Mitigation Strategy (REMS) Removal on Absolute Neutrophil Count (ANC) Monitoring

Wednesday, December 10, 2025

11:00 AM - 12:00 PM

Location: Bayside A, Level 1

Residency Program: Kaiser Permanente - Mid Atlantic States
Residency Program Type: PGY1 (Managed Care Pharmacy)
Residency Program Location: Maryland

Co-Author(s): Jessica L. Ho, Seema H. Ledan

Primary Author(s)

Rhonda A. Moton, MS, BS

Pharmacist
Kaiser Permanente